IL120468A0 - 2-aryl-substituted pyridines their preparation and medicaments containing them - Google Patents
2-aryl-substituted pyridines their preparation and medicaments containing themInfo
- Publication number
- IL120468A0 IL120468A0 IL12046897A IL12046897A IL120468A0 IL 120468 A0 IL120468 A0 IL 120468A0 IL 12046897 A IL12046897 A IL 12046897A IL 12046897 A IL12046897 A IL 12046897A IL 120468 A0 IL120468 A0 IL 120468A0
- Authority
- IL
- Israel
- Prior art keywords
- aryl
- preparation
- medicaments containing
- substituted pyridines
- pyridines
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19610932A DE19610932A1 (de) | 1996-03-20 | 1996-03-20 | 2-Aryl-substituierte Pyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL120468A0 true IL120468A0 (en) | 1997-07-13 |
Family
ID=7788843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12046897A IL120468A0 (en) | 1996-03-20 | 1997-03-17 | 2-aryl-substituted pyridines their preparation and medicaments containing them |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US5925645A (xx) |
| EP (1) | EP0796846B1 (xx) |
| JP (1) | JPH09255574A (xx) |
| AR (1) | AR006318A1 (xx) |
| AT (1) | ATE194832T1 (xx) |
| AU (1) | AU1628097A (xx) |
| BG (1) | BG101339A (xx) |
| BR (1) | BR9701348A (xx) |
| CA (1) | CA2200175A1 (xx) |
| CO (1) | CO4520282A1 (xx) |
| CZ (1) | CZ84397A3 (xx) |
| DE (2) | DE19610932A1 (xx) |
| DK (1) | DK0796846T3 (xx) |
| EE (1) | EE9700060A (xx) |
| ES (1) | ES2150157T3 (xx) |
| GR (1) | GR3034546T3 (xx) |
| HR (1) | HRP970105A2 (xx) |
| HU (1) | HUP9700610A1 (xx) |
| ID (1) | ID16292A (xx) |
| IL (1) | IL120468A0 (xx) |
| MY (1) | MY132490A (xx) |
| NO (1) | NO971269L (xx) |
| NZ (1) | NZ314419A (xx) |
| PL (1) | PL319050A1 (xx) |
| PT (1) | PT796846E (xx) |
| SG (1) | SG50805A1 (xx) |
| SK (1) | SK36197A3 (xx) |
| TN (1) | TNSN97048A1 (xx) |
| TR (1) | TR199700213A2 (xx) |
| ZA (1) | ZA972375B (xx) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| AR008789A1 (es) * | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
| JP2894445B2 (ja) * | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Ｃｅｔｐ活性阻害剤として有効な化合物 |
| DE19709125A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
| AU3285499A (en) | 1998-02-13 | 1999-08-30 | G.D. Searle & Co. | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity |
| JP4546589B2 (ja) * | 1998-04-23 | 2010-09-15 | 武田薬品工業株式会社 | ナフタレン誘導体 |
| DE69925612T2 (de) * | 1998-09-25 | 2006-03-16 | Monsanto Co., Chicago | (r)-chirale halogenierte 1-substituierte amino-(n+1)-alkanolen für die hemmung der aktivität des cholesteryl-ester-transfer-proteins |
| PT1140188E (pt) | 1998-12-23 | 2003-10-31 | Searle Llc | Combinacoes de inibidores do transporte de acidos biliares do ileo e de inibidores da proteina de transferencia de esteres de colesterilo para doencas cardiovasculares. |
| CN1342090A (zh) | 1998-12-23 | 2002-03-27 | G·D·瑟尔有限公司 | 适用于心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合 |
| US6489366B1 (en) | 1998-12-23 | 2002-12-03 | G. D. Searle, Llc | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| HUP0400886A2 (hu) | 1998-12-23 | 2004-07-28 | G.D. Searle Llc | Koleszteril-észter transzfer protein inhibitorok és fibrinsav-származékok kombinációi szív-érrendszeri indikációkhoz |
| WO2000038722A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS |
| JP2002533409A (ja) | 1998-12-23 | 2002-10-08 | ジー．ディー．サール エルエルシー | 心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤および胆汁酸隔離剤の組み合わせ |
| CN1338945A (zh) | 1998-12-23 | 2002-03-06 | G·D·瑟尔有限公司 | 适用于心血管疾病的回肠胆汁酸转运抑制剂和胆汁酸螯合剂组合 |
| US6924313B1 (en) | 1999-09-23 | 2005-08-02 | Pfizer Inc. | Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| US6803388B2 (en) * | 1999-09-23 | 2004-10-12 | Pfizer, Inc. | (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| WO2001068637A2 (en) | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| TNSN03138A1 (en) | 2001-06-22 | 2005-12-23 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF ADSORBATES OF AN AMORPHOUS MEDICINAL PRODUCT |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| ATE444060T1 (de) | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
| EP1426046A4 (en) * | 2001-09-14 | 2005-11-02 | Shionogi & Co | NEW USE OF TRICYCLIC COMPOUNDS |
| BR0213501A (pt) | 2001-11-02 | 2004-08-24 | Searle Llc | Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato |
| CA2471639A1 (en) | 2002-01-17 | 2003-07-31 | Pharmacia Corporation | Novel alkyl/aryl hydroxy or keto thiepines. |
| CA2474838C (en) | 2002-02-01 | 2009-01-06 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| BR0317521A (pt) | 2002-12-20 | 2005-11-16 | Pfizer Prod Inc | Formas de dosagem compreendendo um inibidor da cetp e um inibidor da redutase hmg-coa |
| MXPA05009848A (es) | 2003-03-17 | 2005-12-06 | Japan Tobacco Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia del ester de colesterilo. |
| AU2004222436A1 (en) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate |
| TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
| BRPI0414822A (pt) * | 2003-09-26 | 2006-11-14 | Japan Tobacco Inc | método de inibir a produção de lipoproteìna remanescente |
| PE20050444A1 (es) * | 2003-10-31 | 2005-08-09 | Takeda Pharmaceutical | Compuestos de piridina como inhibidores de la peptidasa |
| FR2873368B1 (fr) * | 2004-07-26 | 2008-01-04 | Merck Sante Soc Par Actions Si | Derives de guanidine et leurs utilisations en therapeutique |
| US8124775B2 (en) * | 2004-12-18 | 2012-02-28 | Bayer Pharma Aktiengesellschaft | Chemical compound and its use |
| EP1844078B1 (en) | 2005-02-03 | 2016-09-28 | Bend Research, Inc | Pharmaceutical compositions with enhanced performance |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| WO2007048027A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| EP1815919A1 (en) * | 2006-02-03 | 2007-08-08 | Uponor Innovation Ab | Making an elongated product |
| DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
| WO2010075069A1 (en) | 2008-12-16 | 2010-07-01 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
| EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| BR112012015152B1 (pt) | 2009-12-21 | 2018-07-03 | Bayer Cropscience Ag | "compostos derivados de bis(difluormetil)pirazóis, seus usos e seu processo de preparação, agente compreendendo os referidos compostos e seu processo de produção, e processo para o combate de fungos fitopatogênicos nocivos" |
| US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| AU2015301891B2 (en) | 2014-08-11 | 2019-12-05 | Angion Biomedica Corporation | Cytochrome P450 inhibitors and uses thereof |
| EP3240778A4 (en) | 2014-12-31 | 2018-07-11 | Angion Biomedica Corp. | Methods and agents for treating disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
| ATE132496T1 (de) * | 1987-07-10 | 1996-01-15 | Hoechst Ag | 3-desmethyl-mevalonsäurederivate, verfahren zu ihrer herstellung, pharmazeutische präparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte |
| US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
| NZ230121A (en) * | 1988-08-29 | 1993-08-26 | Squibb & Sons Inc | Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels |
| DE4244029A1 (de) * | 1992-12-24 | 1994-06-30 | Bayer Ag | Neue substituierte Pyridine |
-
1996
- 1996-03-20 DE DE19610932A patent/DE19610932A1/de not_active Withdrawn
-
1997
- 1997-02-25 HR HR19610932.9A patent/HRP970105A2/hr not_active Application Discontinuation
- 1997-03-07 DE DE59702034T patent/DE59702034D1/de not_active Expired - Fee Related
- 1997-03-07 DK DK97103813T patent/DK0796846T3/da active
- 1997-03-07 PT PT97103813T patent/PT796846E/pt unknown
- 1997-03-07 ES ES97103813T patent/ES2150157T3/es not_active Expired - Lifetime
- 1997-03-07 EP EP97103813A patent/EP0796846B1/de not_active Expired - Lifetime
- 1997-03-07 AT AT97103813T patent/ATE194832T1/de not_active IP Right Cessation
- 1997-03-13 US US08/816,290 patent/US5925645A/en not_active Expired - Fee Related
- 1997-03-13 AU AU16280/97A patent/AU1628097A/en not_active Abandoned
- 1997-03-14 SG SG1997000783A patent/SG50805A1/en unknown
- 1997-03-17 NZ NZ314419A patent/NZ314419A/xx unknown
- 1997-03-17 IL IL12046897A patent/IL120468A0/xx unknown
- 1997-03-17 JP JP9082454A patent/JPH09255574A/ja not_active Ceased
- 1997-03-17 CA CA002200175A patent/CA2200175A1/en not_active Abandoned
- 1997-03-18 TN TNTNSN97048A patent/TNSN97048A1/fr unknown
- 1997-03-18 BG BG101339A patent/BG101339A/xx unknown
- 1997-03-19 SK SK361-97A patent/SK36197A3/sk unknown
- 1997-03-19 BR BR9701348A patent/BR9701348A/pt not_active Application Discontinuation
- 1997-03-19 NO NO971269A patent/NO971269L/no unknown
- 1997-03-19 CZ CZ97843A patent/CZ84397A3/cs unknown
- 1997-03-19 MY MYPI97001168A patent/MY132490A/en unknown
- 1997-03-19 PL PL97319050A patent/PL319050A1/xx unknown
- 1997-03-19 ZA ZA9702375A patent/ZA972375B/xx unknown
- 1997-03-19 AR ARP970101096A patent/AR006318A1/es unknown
- 1997-03-19 HU HU9700610A patent/HUP9700610A1/hu unknown
- 1997-03-20 EE EE9700060A patent/EE9700060A/xx unknown
- 1997-03-20 TR TR97/00213A patent/TR199700213A2/xx unknown
- 1997-03-20 ID IDP970913A patent/ID16292A/id unknown
- 1997-03-20 CO CO97015054A patent/CO4520282A1/es unknown
-
1998
- 1998-12-21 US US09/217,214 patent/US6127383A/en not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402236T patent/GR3034546T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CO4520282A1 (es) | 1997-10-15 |
| TNSN97048A1 (fr) | 2005-03-15 |
| CA2200175A1 (en) | 1997-09-20 |
| DE59702034D1 (de) | 2000-08-24 |
| NZ314419A (en) | 1998-12-23 |
| EP0796846B1 (de) | 2000-07-19 |
| SK36197A3 (en) | 1997-11-05 |
| ID16292A (id) | 1997-09-18 |
| TR199700213A2 (xx) | 1997-10-21 |
| JPH09255574A (ja) | 1997-09-30 |
| HUP9700610A1 (hu) | 2000-08-28 |
| BG101339A (en) | 1998-04-30 |
| PT796846E (pt) | 2000-12-29 |
| AR006318A1 (es) | 1999-08-25 |
| ES2150157T3 (es) | 2000-11-16 |
| DE19610932A1 (de) | 1997-09-25 |
| GR3034546T3 (en) | 2001-01-31 |
| US5925645A (en) | 1999-07-20 |
| EP0796846A1 (de) | 1997-09-24 |
| HU9700610D0 (en) | 1997-05-28 |
| PL319050A1 (en) | 1997-09-29 |
| BR9701348A (pt) | 1998-11-10 |
| NO971269L (no) | 1997-09-22 |
| EE9700060A (et) | 1997-10-15 |
| CZ84397A3 (en) | 1997-10-15 |
| DK0796846T3 (da) | 2000-10-23 |
| MY132490A (en) | 2007-10-31 |
| AU1628097A (en) | 1997-09-25 |
| ATE194832T1 (de) | 2000-08-15 |
| US6127383A (en) | 2000-10-03 |
| MX9702042A (es) | 1997-09-30 |
| HRP970105A2 (en) | 1998-04-30 |
| SG50805A1 (en) | 1998-07-20 |
| ZA972375B (en) | 1997-09-25 |
| NO971269D0 (no) | 1997-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL120468A0 (en) | 2-aryl-substituted pyridines their preparation and medicaments containing them | |
| IL121235A0 (en) | Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| IL116325A0 (en) | Substituted 1h-imidazoles their preparation and use | |
| IL104843A0 (en) | Sulphonylbenzyl-substituted pyridones,their preparation and pharmaceutical compositions containing them | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| IL114795A0 (en) | N-benzylindole- and benmzopyrazole derivatives their preparation and use | |
| PL319758A1 (en) | Bicyclic tetrahydropyrasole pyridines and their application as medicines | |
| HU9501086D0 (en) | Organoaluminoxy product, preparation and use | |
| NZ332309A (en) | Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments | |
| IL116525A0 (en) | Piperazinedione derivatives their preparation and use | |
| IL118485A (en) | 5,6-dihydro-9H-pyrazolo¬3,4-c¾-1,2,4-triazolo¬4,3-a¾ pyridines and pharmaceutical compositions containing them | |
| HUP9903886A3 (en) | Azacycloalcane derivatives, preparation thereof and their applications in therapy | |
| IL105647A0 (en) | Biphenylmethyl-substituted pyridones,their preparation and pharmaceutical compositions containing them | |
| ZA988285B (en) | 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments | |
| IL113151A0 (en) | Imidazo [1,2-a]pyrazin-4-one derivatives their preparation and medicinal products containing them | |
| IL116710A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
| HUP9903715A3 (en) | 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols, their use and medicaments containing them | |
| IL116712A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
| IL130348A0 (en) | Imidazopyridazines and medicaments containing the same | |
| NZ295368A (en) | Nitrobenzamide derivatives; preparation and antiarrythmic medicaments | |
| IL120637A0 (en) | Retinoids their preparation and pharmaceutical compositions containing them | |
| IL116711A0 (en) | Substituted 2-phenylpyridines their preparation and use | |
| HUP0004661A3 (en) | Polyhydroxybutylpyrazines, their preparation and medicines containing them | |
| ZA9811344B (en) | New azulene derivatives and medicaments containing same |